Khalsa, Jasneet Kaur
Cheng, Nina http://orcid.org/0000-0002-7306-2101
Keegan, Joshua
Chaudry, Ameen
Driver, Joseph
Bi, Wenya Linda
Lederer, James
Shah, Khalid http://orcid.org/0000-0002-5474-0974
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (CA138922)
U.S. Department of Health & Human Services | National Institutes of Health (CA140744)
Article History
Received: 4 November 2019
Accepted: 9 July 2020
First Online: 6 August 2020
Competing interests
: K.S. owns equity in and is a member of the Board of Directors of Amasa Therapeutics, a company developing stem cell-based therapies for cancer. K.S.’s interests were reviewed and are managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. The remaining authors declare no competing interests.